Research | Quality Assessment of Real-World Data

RWD-Cockpit: Application for quality assessment of real-world data

ABSTRACT: Digital technologies are transforming the healthcare system. A large part of information is generated as real-world data (RWD). Data from electronic health records and digital biomarkers have the potential to reveal associations between the benefits and adverse events of medicines, establish new patient stratification principles, expose unknown disease correlations, and inform on preventive measures. The impact for healthcare payors and providers, the biopharmaceutical industry and governments, is massive in terms of health outcomes, quality of care and cost. However, a framework to assess preliminary quality of RWD is missing, thus hindering the conduct of population-based observational studies to support regulatory decision-making and real-world evidence (RWE).

Read the full publication here.

Related work

News

  1. Evidation Launches Temporal Proteomics Platform to Power Autoimmune Research
    January 8, 2026
    Read

  2. Evidation Shares Insights on Real-World GLP-1 Dosing Behaviors from Over 60,000 Individuals
    December 16, 2025
    Read

  3. Evidation Appoints Dr. Ghazanfar Khan as Chief Medical Officer
    December 2, 2025
    Read

Babrak L, Smakaj E, Agac T, Asprion P, Grimberg F, Van der Werf D, van Ginkel E, Tosoni D, Clay I, Degan M, Brodbeck D, Natali E, Schkommodau E, MIho E

Read the full publication here.

Related Therapeutic Areas: